Skip to content

A clinical study of 0.01% atropine eye drops in children with intermittent exotropia combined with myopia

A clinical study of 0.01% atropine eye drops in children with intermittent exotropia combined with myopia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039827
Enrollment
Unknown
Registered
2020-11-11
Start date
2020-12-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intermittent exotropia combined with myopia

Interventions

Intervention group:0.01% atropine eye drops
Control group:placebo eye drops

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Basic intermittent exotropia; 2. 6 to 12 years of age when agreed to join; 3. Myopic refraction = 10 prism diopters (PD) at distance measured by the prism and alternate cover test (PACT). In addition, the investigator and the childs family had to be. willing to observe the IXT without treatment for 3 years unless specific criteria for deterioration were met.

Exclusion criteria

Exclusion criteria: 1. Having amblyopia or other eye disease that affects vision; 2. Myopic refraction 2 D; 4. Serious health problems affecting follow-up or failure to cooperate with examinations; 5. Participate in other intervention tests; 6. Previous use of atropine or orthokeratology lens or other optical methods for myopia control; 7. Allergy to atropine; 8. Peripheral anterior chamber depth < 1/3 corneal thickness.

Design outcomes

Primary

MeasureTime frame
refraction diopter;axial length;exodeviation magnitude;deterioration rate;stereoacuity;intermittent exotropia control scale;

Secondary

MeasureTime frame
pupil diameter;accommodation;accommodative convergence/accommodation;retinal thickness;vessel density;

Countries

China

Contacts

Public ContactLiu Hu

The First Affiliated Hospital with Nanjing Medical University

liuhu@njmu.edu.cn+86 25 68136470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026